CN Stock MarketDetailed Quotes
600538 Beihai Gofar Chuanshan Biological
- 3.39
- -0.22-6.09%
Market Closed Oct 11 15:00 CST
1.78BMarket Cap-20059P/E (TTM)
3.61High3.38Low101.59KlotVolume3.61Open3.61Pre Close35.27MTurnover1.94%Turnover RatioLossP/E (Static)524.20MShares5.4552wk High2.08P/B1.78BFloat Cap2.9052wk Low3.97Limit Up524.20MShs Float19.58Historical High3.25Limit Down6.37%Amplitude1.85Historical Low--Dividend TTM3.47Avg Price57.45KlotAsk--Div YieldTTM100Lot Size41.61KlotBid
Beihai Gofar Chuanshan Biological Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.02%176.74M | -13.79%87.57M | -19.69%369.15M | -16.30%283.27M | -11.41%194.25M | -15.94%101.58M | 8.23%459.68M | 11.09%338.43M | 15.34%219.26M | 28.53%120.84M |
| Operating revenue | -9.02%176.74M | -13.79%87.57M | -19.69%369.15M | -16.30%283.27M | -11.41%194.25M | -15.94%101.58M | 8.23%459.68M | 11.09%338.43M | 15.34%219.26M | 28.53%120.84M |
| Other operating revenue | 4.16%1.34M | ---- | -14.29%2.09M | ---- | 0.52%1.28M | ---- | -10.81%2.44M | ---- | -3.74%1.28M | ---- |
| Total operating cost | -5.12%178.43M | -5.08%91.4M | -10.45%381.31M | -9.00%279.62M | -5.54%188.05M | -11.17%96.29M | 4.48%425.78M | 6.53%307.29M | 11.58%199.08M | 22.81%108.4M |
| Operating cost | -8.91%133.18M | -9.28%68.53M | -16.29%277.46M | -13.11%214.05M | -9.36%146.21M | -16.08%75.54M | 5.17%331.47M | 8.73%246.34M | 15.78%161.31M | 30.09%90.01M |
| Operating tax surcharges | 2.69%1.61M | -1.94%734.29K | -4.38%3.44M | -4.78%2.36M | -2.97%1.57M | -11.51%748.79K | -2.04%3.59M | 5.12%2.48M | 9.67%1.62M | 13.42%846.19K |
| Operating expense | 14.30%16.59M | 23.29%8.48M | 5.37%36.74M | -5.98%23.09M | -3.65%14.51M | 4.20%6.88M | -9.48%34.87M | -8.44%24.56M | -9.35%15.06M | -17.64%6.6M |
| Administration expense | -1.49%23.87M | 1.80%12.45M | 5.26%53.97M | 23.80%37.37M | 25.28%24.23M | 24.92%12.23M | 13.95%51.28M | 0.47%30.18M | -2.91%19.34M | -0.50%9.79M |
| Financial expense | 72.01%-442.41K | 37.91%-479.68K | 19.59%-3.06M | -18.05%-2.36M | 1.04%-1.58M | -94.59%-772.55K | 4.75%-3.81M | 17.73%-2M | 16.06%-1.6M | 65.84%-397.01K |
| -Interest expense (Financial expense) | 449.93%921.06K | -52.30%73.32K | -26.21%372.68K | -78.99%168.92K | -63.22%167.49K | -38.72%153.7K | -4.30%505.05K | 564.72%803.84K | 399.33%455.39K | 845.85%250.84K |
| -Interest Income (Financial expense) | 20.71%-1.51M | 39.17%-592.36K | 24.08%-3.58M | 23.62%-2.43M | 19.79%-1.9M | -34.97%-973.85K | -17.82%-4.71M | -39.24%-3.18M | -12.98%-2.37M | 56.46%-721.53K |
| Research and development | 16.49%3.62M | 1.16%1.68M | 52.27%12.76M | -10.72%5.11M | -7.35%3.1M | 7.71%1.66M | -8.36%8.38M | 12.06%5.73M | 12.21%3.35M | -5.43%1.55M |
| Credit Impairment Loss | 27.71%-2.81M | ---- | -7.01%-5.76M | 21.52%-3.88M | 21.52%-3.88M | ---- | -91.41%-5.38M | -57.71%-4.95M | -57.71%-4.95M | ---- |
| Asset Impairment Loss | 93.24%-12.35K | -235.32%-6.43K | -5,101.97%-58.42M | 61.07%-182.62K | -70.12%-182.62K | 91.22%-1.92K | 18.29%-1.12M | -174.81%-469.16K | -42.03%-107.35K | -93.31%-21.83K |
| Other net revenue | 11.35%-12.02M | -24.24%-7.4M | -882.38%-65.61M | -301.03%-17.13M | -107.56%-13.56M | -194.89%-5.96M | 511.97%8.39M | 330.12%8.52M | -92.39%-6.53M | -201.31%-2.02M |
| Fair value change income | --21.73K | ---- | 2,767.42%7.13M | ---- | ---- | ---- | -90.24%-267.14K | ---- | ---- | ---- |
| Invest income | 5.17%-9.7M | -23.35%-7.77M | -177.30%-9.79M | -212.24%-14.06M | -279.59%-10.23M | -152.33%-6.3M | 1,888.73%12.66M | 1,738.49%12.52M | -438.45%-2.7M | -218.96%-2.5M |
| -Including: Investment income associates | -1.03%-9.98M | -22.21%-7.6M | -173.46%-9.9M | -207.47%-13.46M | -266.41%-9.88M | -149.31%-6.22M | 1,321.33%13.47M | 1,438.15%12.52M | -301.69%-2.7M | -218.96%-2.5M |
| Asset deal income | 1,219.16%1.38K | ---- | ---- | -100.11%-123.08 | -100.11%-123.08 | -100.98%-123.08 | 244.75%113.6K | 1,891.43%114.09K | 1,862.53%112.25K | 1,710.54%12.5K |
| Other revenue | -35.01%484K | 8.99%371.66K | -48.14%1.23M | -24.16%988.68K | -32.85%744.71K | -29.62%341K | -19.79%2.38M | 459.69%1.3M | 505.79%1.11M | 2,494.35%484.51K |
| Operating profit | -86.44%-13.71M | -1,584.87%-11.23M | -283.90%-77.76M | -133.99%-13.48M | -153.87%-7.35M | -106.40%-666.52K | 178.95%42.28M | 217.95%39.66M | 64.75%13.65M | 105.13%10.42M |
| Add:Non operating Income | -73.42%41.2K | -63.75%56.19K | 474.16%442.7K | 249.14%156.1K | 246.68%155K | 245.58%155K | -89.73%77.11K | -94.09%44.71K | 182.13%44.71K | 70.77%44.85K |
| Less:Non operating expense | 33,215.76%24.16K | 5,262.87%3.89K | -2.53%245.11K | -96.93%7.26K | -99.91%72.53 | -99.88%72.5 | 107.76%251.46K | -46.31%236.83K | 20.44%80.93K | 2,743.92%59.66K |
| Total profit | -90.21%-13.69M | -2,084.89%-11.18M | -284.19%-77.57M | -133.78%-13.33M | -152.88%-7.2M | -104.92%-511.59K | 166.71%42.11M | 208.62%39.47M | 65.34%13.61M | 103.87%10.41M |
| Less:Income tax cost | -7.37%1.16M | -69.15%496.99K | -34.20%3.59M | -81.00%990.85K | -68.51%1.25M | -31.25%1.61M | -6.83%5.46M | 16.24%5.21M | 28.61%3.98M | 74.10%2.34M |
| Net profit | FPtoL-14.85M | FPtoL-11.67M | SL-81.16M | SL-14.33M | SL-8.45M | SL-2.12M | 269.20%36.65M | 312.53%34.26M | 87.48%9.63M | 114.52%8.06M |
| Net profit from continuing operation | -75.73%-14.85M | -450.08%-11.67M | -321.45%-81.16M | -141.82%-14.33M | -187.76%-8.45M | -126.32%-2.12M | 269.20%36.65M | 312.53%34.26M | 87.48%9.63M | 114.52%8.06M |
| Less:Minority Profit | -3.22%1.26M | 30.28%683.28K | -36.39%1.15M | -0.38%1.4M | 43.44%1.3M | -20.32%524.47K | 422.82%1.81M | 181.51%1.41M | 70.88%907.03K | 235.88%658.24K |
| Net profit of parent company owners | -65.20%-16.11M | -366.89%-12.36M | -336.23%-82.31M | -147.88%-15.73M | -211.81%-9.75M | -135.74%-2.65M | 232.25%34.84M | 320.93%32.85M | 89.39%8.72M | 74.53%7.41M |
| Earning per share | ||||||||||
| Basic earning per share | -50.00%-0.03 | -100.00%-0.02 | -328.57%-0.16 | -150.00%-0.03 | -200.00%-0.02 | -200.00%-0.01 | 250.00%0.07 | 500.00%0.06 | 100.00%0.02 | 0.00%0.01 |
| Diluted earning per share | -50.00%-0.03 | -100.00%-0.02 | -328.57%-0.16 | -150.00%-0.03 | -200.00%-0.02 | -200.00%-0.01 | 250.00%0.07 | 500.00%0.06 | 100.00%0.02 | 0.00%0.01 |
| Other composite income | ||||||||||
| Total composite income | -75.73%-14.85M | -450.08%-11.67M | -321.45%-81.16M | -141.82%-14.33M | -187.76%-8.45M | -126.32%-2.12M | 269.20%36.65M | 312.53%34.26M | 87.48%9.63M | 114.52%8.06M |
| Total composite income of parent company owners | -65.20%-16.11M | -366.89%-12.36M | -336.23%-82.31M | -147.88%-15.73M | -211.81%-9.75M | -135.74%-2.65M | 232.25%34.84M | 320.93%32.85M | 89.39%8.72M | 74.53%7.41M |
| Total composite income of minority owners | -3.22%1.26M | 30.28%683.28K | -36.39%1.15M | -0.38%1.4M | 43.44%1.3M | -20.32%524.47K | 422.82%1.81M | 181.51%1.41M | 70.88%907.03K | 235.88%658.24K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data